Bartlett & Co’s Bio-Techne TECH Stock Holding History

Bartlett & Co’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$13K	Buy	+172	New	+$11.3K	﹤0.01%	967
2021 Q1	–	Sell	-44	Closed	-$3K	–	1169
2020 Q4	$3K	Buy	+44	New	+$3.19K	﹤0.01%	874
2015 Q1	–	Sell	-96	Closed	-$2K	–	784
2014 Q4	$2K	Buy	+96	New	+$2.2K	﹤0.01%	787

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Bartlett & Co's TECH Position: Q4 2023 in Review

Bartlett & Co opened a new position in Bio-Techne (TECH) in Q4 2023: 172 shares worth $13K. The stake represents ﹤0.01% of the portfolio and ranks #967 among its holdings. This is a return to the name: Bartlett & Co previously reported a position in TECH as recently as Q4 2020.

Bartlett & Co first reported a position in TECH in Q4 2014 and has held it in 3 quarters since. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

Bartlett & Co held 172 shares of Bio-Techne worth $13K as of Q4 2023.
Bio-Techne was a new Bartlett & Co position in Q4 2023.
Bio-Techne made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #967 holding.
Bartlett & Co first reported a position in Bio-Techne in Q4 2014 and has held it in 3 quarters since.
531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.